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ABSTRACT: Based on the saposin-A (SapA) scaﬀold
protein, we demonstrate the suitability of a size-adaptable
phospholipid membrane-mimetic system for solution
NMR studies of membrane proteins (MPs) under close-
to-native conditions. The Salipro nanoparticle size can be
tuned over a wide pH range by adjusting the saposin-to-
lipid stoichiometry, enabling maintenance of suﬃciently
high amounts of phospholipid in the Salipro nanoparticle
to mimic a realistic membrane environment while
controlling the overall size to enable solution NMR for a
range of MPs. Three representative MPs, including one G-
protein-coupled receptor, were successfully incorporated
into SapA-dimyristoylphosphatidylcholine nanoparticles
and studied by solution NMR spectroscopy.
Around 30% of all genes encode integral membraneproteins (MPs),1 which have a range of important
biological functions, leading to their involvement in many
diseases. Nevertheless, characterization of their structure and
dynamics remains heavily under-represented. The biggest
challenge for in vitro studies of MPs is ﬁnding a suitable
mimic of the native lipid membrane bilayer, which is suﬃciently
stabilizing for structural studies but which maintains the
protein’s biological function and ability for interaction with
ligands and other protein partners.2 Detergents are the most
commonly used membrane mimetic for MP characterization
due to the range available, their simplicity of use, and, for NMR
spectroscopy, the relatively small size of the resulting protein−
detergent complex. However, detergents may interfere with
ligand binding and downstream functional assays,3 disrupt
protein−protein interactions,4 lack crucial protein−lipid
contacts,5 interfere with protein dynamics,6,7 and denature
soluble binding partners,8 making it diﬃcult to study signaling
across the membrane, such as G-protein-coupled receptor
(GPCR) signaling. Small bicelles provide a more lipid-like
environment. While they may provide high-quality spectra, at
sizes suitable for solution NMR there is likely to be rapid
mixing between the detergent and lipid components, so this
does not provide a pure bilayer environment.9
The nanodisc system provides an alternative to detergent
micelles and small bicelles for MP studies. The disc-like
particles consist of a phospholipid bilayer enclosed by two belt-
like membrane-scaﬀold proteins (MSPs),10 with the MP of
interest incorporated into the center of the discs. Nanodiscs
have been widely used as a detergent-free environment,
providing a native-like lipid bilayer suitable for MP character-
ization.11 The suitability of the MSP nanodisc system for
solution NMR has been demonstrated,12,13 along with the
functional relevance of lipid bilayer mimetics for conforma-
tional equilibria of receptors and ion channels.14−16 However,
the relatively large nanodisc particle size is a limitation for
solution NMR. Several truncated MSP constructs have been
designed to generate smaller nanodiscs, and these modiﬁcations
facilitated the ﬁrst solution NMR structure of a MP embedded
in phospholipid nanodiscs.7 Further improvements have been
achieved through the introduction of covalently circularized
nanodiscs, which result in a well-deﬁned particle size rather
than a broad distribution in sizes that require additional
separation through chromatographic methods.17 Although MSP
nanodiscs have been used successfully in a number of NMR
studies, multiple MSP constructs must be tested and the lipid
ratio determined empirically for each in order to ﬁnd the
optimal system for every MP of interest, resulting in an
extensive screening procedure as demonstrated recently for
OprH and OprG.18,19 There are concerns that the smaller MSP
constructs may be unable to incorporate suﬃcient lipid
molecules with larger MPs to faithfully mimic a native-like
membrane bilayer and that some MPs might interact with the
scaﬀold protein. Consequently, alternative nanodisc systems
that can adapt to a range of MP sizes are of interest. We
describe here applications to solution NMR studies based on
the saposin-A (SapA) scaﬀold protein.
SapA, a sphingolipid activator protein in lysosome,20 has
been observed to form disc-like particles with liposomes of
varying lipid composition at pH 4.8.21 The crystal structures of
SapA revealed a closed conformation in its apo form, which
opens in a jack-knife style to interact with a lauryldimethyl-
amine-N-oxide (LDAO) mini-bilayer.21 Two V-shaped SapAs
surrounding the bilayer are in a head-to-tail arrangement, in
contrast to a continuous belt found in the MSP nanodiscs.
SapA has the potential in this arrangement to incorporate MPs
of various sizes by altering the number of SapAs per
nanoparticle, removing the need to screen multiple scaﬀold
protein constructs. This idea was conﬁrmed previously in a
cryo-electron microscopy (EM) study, where an archaeal
mechanosensitive channel T2 (32.9 kDa), which is a putative
homopentamer, and a bacterial homotetramer peptide trans-
porter PepTSo2 (56 kDa) were both incorporated into Salipro
nanoparticles at pH 7.4.22 This study demonstrated that Salipro
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nanoparticles show promising ﬂexibility, enabling incorporation
of a range of protein sizes without the need to screen multiple
diﬀerent scaﬀold−protein constructs. Thus, Salipro nano-
particles have the ﬂexibility of bicelles, allowing incorporation
of a range of protein sizes, but with the beneﬁt of a detergent-
free, lipid bilayer environment. This size-adaptability will enable
use of the same nanoparticle system for diﬀerent studies, e.g.,
cryo-EM studies of a multiprotein complex along with NMR
studies of constituent MPs from the complex, facilitating
integrated structural studies. Motivated by this, we decided to
explore the ability of Salipro nanoparticles to accommodate
small to medium size MPs and to test their suitability for
solution NMR studies.
In this study, we describe a method to produce SapA-
dimyristoylphosphatidylcholine (DMPC) nanoparticles with
controllable sizes at various pH values (4.8−7.4) typically used
in protein NMR studies. Three model proteins were
incorporated into the SapA-DMPC nanoparticles, including a
GPCR, showing the broad applicability of this system to MPs of
diﬀerent sizes and folds and at diﬀerent pH values. The
structural integrity and functionality of the MPs in SapA-
DMPC nanoparticles were characterized by solution NMR
spectroscopy.
It has been shown that SapA interacts with liposomes at pH
4.8,21 to form disc-like particles, but n-dodecyl β-D-maltoside
(DDM)-solubilized lipids are required at neutral pH 7.4.22
Here, we investigated the role of detergent in Salipro
nanoparticle formation in more detail. Starting with a cloudy
DMPC stock solution without DDM in which lipids remain
insoluble, SapA was incubated with DMPC in diﬀerent pH
buﬀers at 37 °C for 10 min, and the size of the resulting
particles was analyzed by size-exclusion chromatography
(SEC). SapA-DMPC nanoparticles with a molecular weight
(MW) of 37 kDa, which is consistent with the value reported
previously,21 were formed at pH 4.8 (Figure S1). In contrast,
most of the SapA at pH 6 and 7.4 remained the same size as in
the apo form, indicating SapA in a closed conformation (Figure
S1). We also observed that SapA is insoluble in the absence of
DMPC at pH 4.8 (Figure S1). Consequently, we hypothesized
that low pH destabilizes the closed form of SapA, causing either
recruitment of DMPC to form Salipro nanoparticles or
insolubility in the absence of lipids (Figure S2a). In contrast,
SapA remains in the closed conformation at high pH, limiting
its ability to form Salipro nanoparticles.
To encourage opening of SapA at higher pH, we investigated
the interaction of SapA with DDM, which, unlike lipids, is
soluble in water, at pH 7.4. We observed a signiﬁcant peak shift
in SEC, indicating the formation of a stable SapA-DDM
complex (Figure 1a). A blue-shift and the increased intensity in
intrinsic ﬂuorescence (Figure 1b), as well as the downﬁeld shift
of the tryptophan side-chain signal in 1D 1H NMR (Figure 1c),
observed for SapA-DDM conﬁrm that the environment of the
only tryptophan in SapA has become more hydrophobic.
Similar but more prominent changes were also observed in
SapA-DMPC nanoparticles at pH 4.8 (Figure 1), indicating that
SapA adopts an open-like conformation in complex with DDM
at pH 7.4. Therefore, we hypothesized that DDM can promote
SapA-DMPC nanoparticle formation by increasing the DMPC
solubility and “catalyzing” SapA opening (Figure S2b).
Next, 0.2% DDM was included in the assembly mixture to
assist nanoparticle formation. DDM was removed using
detergent adsorbent beads (Figure 2a), and complete detergent
removal was conﬁrmed by DDM quantiﬁcation using the 2,6-
dimethylphenol method23 and 1D 1H NMR (data not shown)
to rule out the formation of mixed detergent−lipid Salipro
nanoparticles. SEC revealed the formation of two sizes of SapA-
DMPC nanoparticles when diﬀerent SapA:DMPC ratios were
screened at pH 6 (Figure S3a). The optimal assembly
SapA:DMPC ratios used to generate a uniform size of Salipro
nanoparticles were 1:15 and 1:45 at pH 6. The ﬁnal ratio after
SEC was measured using 280 nm absorbance and molybdate
assay,24 indicating a ratio of 1:14 and 1:45, respectively (Figure
2b). Based on the MW and the SapA:DMPC ratio, we propose
that the small Salipro nanoparticles are composed of three
SapA and 42 DMPC molecules, whereas the large Salipro
nanoparticles are composed of four SapA and 180 DMPC
molecules, hereafter called Salipro3 and Salipro4, respectively.
The disc-like shape is conﬁrmed by negative-stain EM (Figures
2c and S3d); a side view of the Salipro nanoparticles stacked
together can be seen, as well as a top view of single Salipro
nanoparticles. Stacking is also observed in EM images of MSP
nanodiscs.25 The same size-tunable characteristic was also
found at pH 4.8 and 7.4 (Figure S3b,c). SapA can also form
Salipro nanoparticles when mixtures of lipids are used, as
Figure 1. Biophysical characterization of free SapA, SapA-DDM, and
SapA-DMPC nanoparticles. (a) Size-exclusion chromatography. (b)
Fluorescence spectroscopy. (c) 1D 1H NMR spectroscopy. Trypto-
phan indole signals are indicated by *.
Figure 2. Generation of SapA-DMPC nanoparticles at pH 6. (a)
Schematic representation of the SapA-DMPC nanoparticle assembly.
(b) SEC of SapA-DMPC with initial mixing SapA:DMPC ratios of
1:15 (blue) and 1:45 (red) at pH 6. DMPC was quantiﬁed by
molybdate assay24 (open circle). The proposed SapA arrangement is
indicated. (c) Negative-stain EM images of Salipro3. Scale bar, 50 nm.
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shown, e.g., for DMPC/DMPG, resulting in homogeneous
particles similar in size to the ones with pure DMPC (Figure
S4).
To test whether SapA-DMPC nanoparticles can be used in
MP NMR studies, we ﬁrst investigated the incorporation of the
16.5 kDa bacterial outer membrane protein X (OmpX). OmpX
embedded in phospholipid MSP nanodiscs has previously been
studied extensively by NMR spectroscopy, providing a good
point of comparison.6,7,26
The self-assembly of OmpX embedded in SapA-DMPC
nanoparticles was achieved by mixing SapA, DMPC, and DPC-
solubilized OmpX at a ratio of 10:50:1, at pH 6, with 0.2%
DDM to facilitate opening of SapA, followed by a detergent
removal step. OmpX remained in solution and showed a
symmetrical peak at 14.1 mL (84 kDa) by SEC (Figure S5),
slightly smaller than that of OmpX in MSP1D1ΔH5 (ΔH5)
nanodiscs (107 kDa).7 We suggest that OmpX was
incorporated into Salipro3. A 2D [
1H,15N]-SOFAST-TROSY
spectrum was recorded on non-deuterated15N-labeled OmpX
(Figure 3) to assess the structural integrity of OmpX in
Salipro3. The resulting spectrum is of good quality, even
without deuteration, and, with regard to the peak positions,
very similar in appearance to a previously presented spectrum
of OmpX in ΔH5-DMPC nanodiscs, allowing transfer of the
reported backbone assignments on the basis of peak proximity
(assignments kindly provided by Dr. Stefan Bibow).6 Clearly,
the spectrum quality for the latter in ΔH5-DMPC nanodiscs is
superior due to the use of deuterated OmpX.26 However,
rotational correlation time measurements using 15N TRACT27
indicate that the Salipro nanoparticle-embedded OmpX is
smaller in size (τc = 28 ns, calculated MW = 87 kDa) compared
to the ΔH5 nanodiscs (τc = 34 ns, calculated MW = 107 kDa).
Accordingly, using deuterated protein would result in high-
quality spectra in Salipro nanoparticles. A chemical-shift-based
comparison of OmpX in Salipro3, with the same protein
embedded in ΔH5-DMPC6 or in DPC micelles,7 conﬁrms the
DMPC bilayer environments of OmpX to be most similar to
Salipro3 (Figure S6). This supports the proper incorporation of
the protein into Salipro3. Interestingly, the residues with the
largest chemical shift diﬀerences between the SapA-DMPC
nanoparticles and SapA-DMPC/DMPG nanoparticles mostly
reside in loops 1 and 3 (Figure S6c,d), indicating that the
phospholipid headgroup composition has a strong inﬂuence on
speciﬁc regions of the MP.
To explore the more general suitability of the Salipro
nanoparticle system, the incorporation of other MPs with
diﬀerent structural folds was investigated. A seven-trans-
membrane helical protein, the phototaxis receptor sensory
rhodopsin II (pSRII) (26.4 kDa), was successfully incorporated
using the same protocol and ratio. UV−vis analysis conﬁrmed
the native conformation of pSRII with its characteristic 498 nm
absorbance. SEC and negative-stain EM images show
homogeneous particles with MW ≈ 200 kDa (Figure S7);
thus, we suggest that pSRII was embedded in Salipro4. Based
on UV−vis and SDS−PAGE quantitative analyses, the
SapA:pSRII ratio was determined to be 2:1 (Figure S8),
suggesting dimeric pSRII in Salipro4. A 2D [
1H,15N]-SOFAST-
TROSY spectrum (Figure S9) showed that although the NMR
spectral quality is worse compared to that of monomeric pSRII
in c7-DHPC micelles,28 as expected due to the larger MW, a
similar overall backbone ﬁngerprint can be observed.
Perdeuteration would further improve the spectral quality for
more extensive solution NMR studies of pSRII in SapA-DMPC
nanoparticles.
Next, we used thermostabilized turkey β1-adrenergic receptor
(β1AR) (36 kDa), a GPCR, to test if MPs in the SapA-DMPC
nanoparticles retains the ability to functionally interact with
binding partners. It has been shown previously that β1AR
interacts with the full agonist isoprenaline and the G-protein
mimicking nanobody Nb80 using detergent micelles.29 Here,
we incorporated [13Cε-methionine] β1AR (Figure S10) into
SapA-DMPC nanoparticles at pH 7.4 (Figure S11) due to the
limited stability of β1AR at low pH. The
13C HMQC spectrum
of β1AR in the apo state revealed 13 peaks for the 12
methionine residues, with substantially varying intensities,
indicating that diverse parts of the receptor apo form diﬀer in
their dynamics. Several signals showed chemical shift
perturbation upon isoprenaline binding (Figure 4, arrows),
indicating that the receptor changes conformation when bound
to an activating ligand. The substantial broadening observed for
many of the NMR signals in the full agonist bound state further
suggests that the receptor is dynamically exchanging between
several conformations on a μs-to-ms time scale. Addition of G-
Figure 3. 2D [1H,15N]-SOFAST-TROSY spectrum of non-deuterated
15N-labeled OmpX in SapA-DMPC nanoparticles.
Figure 4. Overlay of the 2D 13C-SOFAST-HMQC spectra of [13Cε-
methionine] β1AR in the apo state (blue), the isoprenaline-bound
state (green), and the isoprenaline-Nb80-bound ternary complex
(red).
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protein mimicking Nb80 to form a fully active ternary complex
induced further dramatic chemical shift perturbations. At the
same time the recovery of peak intensities seems to indicate
that the isoprenaline-Nb80-bound ternary complex is con-
formationally more restricted, comparable to NMR observa-
tions for the β2-adrenergic receptor.
30 While these studies show
the successful embedding of β1AR in Salipro nanoparticles as a
functional receptor, the individual resonance assignments will
be presented as the topic of further investigations.
In conclusion, we have presented a ﬂexible phospholipid
nanodisc system based on the SapA scaﬀold protein which can
accommodate MPs with diﬀerent fold and size over a wide pH
range and allows interaction with protein binding partners to be
studied. Based on the three proteins studied here, we observe
high incorporation eﬃciencies into Salipro nanoparticles of
>80%. Furthermore, Salipro nanoparticle NMR samples were
stable over extended periods of time (Figure S13). The
compatibility of the SapA system with NMR spectroscopy
provides an opportunity to study MPs’ structure, dynamics, and
molecular interactions, such as GPCR signaling in a more
native lipid environment, demonstrating the potential of the
SapA nanodisc system for the MP ﬁeld.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/jacs.7b06730.








This work was funded in part through a BBSRC research grant
to D.N. (BB/K01983 X/1), studentship support to C.H.C.
(Taiwan Cambridge Scholarship), and studentship support to
A.S. (MRC Industrial CASE).
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
We thank Dr. Janet Deane for providing the SapA plasmid and
Dr. Dijun Du for help with EM. NMR resonance assignments
of OmpX in MSP1D1ΔH5-DMPC nanodiscs were kindly
provided by Dr. Stefan Bibow. We thank the BBRSC, Taiwan
Cambridge Scholarship and MRC for funding.
■ REFERENCES
(1) Wallin, E.; von Heijne, G. Protein Sci. 1998, 7, 1029.
(2) Cross, T. A.; Murray, D. T.; Watts, A. Eur. Biophys. J. 2013, 42,
731.
(3) Ding, Y.; Fujimoto, L. M.; Yao, Y.; Plano, G. V.; Marassi, F. M.
Biochim. Biophys. Acta, Biomembr. 2015, 1848, 712.
(4) Zhang, M.; Huang, R.; Im, S. C.; Waskell, L.; Ramamoorthy, A. J.
Biol. Chem. 2015, 290, 12705.
(5) Laganowsky, A.; Reading, E.; Allison, T. M.; Ulmschneider, M.
B.; Degiacomi, M. T.; Baldwin, A. J.; Robinson, C. V. Nature 2014,
510, 172.
(6) Frey, L.; Lakomek, N. A.; Riek, R.; Bibow, S. Angew. Chem., Int.
Ed. 2017, 56, 380.
(7) Hagn, F.; Etzkorn, M.; Raschle, T.; Wagner, G. J. Am. Chem. Soc.
2013, 135, 1919.
(8) Warschawski, D. E.; Arnold, A. A.; Beaugrand, M.; Gravel, A.;
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